GREENVILLE – Perfusio, a Greenville, North Carolina-based startup that spun out from East Carolina University as RFPi, has closed an additional round of funding.
According to a securities filing, the company has raised $1,597,580 from 26 investors. And there’s more room for future investment coming into the company, as the filing notes that the total offering amount is $2,650,000.
The filing notes that the securities offered is an option, warrant, or another right to acquire another security. It was signed by the company’s attorney at the end of January.
The company is still led by its founder, Phil Hodges, who is the firm’s CEO, according to the company’s website. Hodges is also the founder of Metrics, which was sold in 2012 for $120 million to Australian company Mayne Pharma Group, Ltd.
“We are commercializing a transformational new medical imaging technology, backed by a leadership team with deep roots in healthcare business management, as well as scientific expertise,” reads the company’s website.
With FDA clearance in hand, Greenville med device startup raises $2M, wants $5M more
This is just the latest capital raise
In 2019, while still operating at RFPi, the company received FDA approval to begin marketing a blood flow and perfusion imaging device, which at the time was called iCertainty. The firm also landed a Phase II Small Business Technology Transfer grant in 2019. That grant was the first ever awarded by the National Institutes of Health in Eastern North Carolina or with East Carolina University as the academic research partner, WRAL TechWire previously reported.
The firm would go on to raise close to $5 million in capital, first disclosed in 2020 and then in an amended filing in 2021. Also in 2021, the company changed its name from RFPi to Perfusio.
Richard Balot, the founder and CEO of Victra Wireless, which bought a company last year, is listed as a director of PERFUSIO, according to the company’s SEC filing.
The company has previously received backing from the North Carolina Biotechnology Center.
